Report date: Nov 6,2024
Conflict count: 361874
Publisher: Focus Endocrinology
Title count: 1
Conflict count: 7


==========================================================

Created: 2024-05-25 08:31:29
ConfID: 7323270
CauseID: 1630467729
OtherID: 1630219793
JT: FOCUS Endocrinology
MD: Azizova,5,1,34,2024,Ovarian reserve in obese patients: where do the eggs disappear?
DOI: 10.15829/2713-0177-2024-5-1-05(Journal) (7323270-N)
DOI: 10.62751/2713-0177-2024-5-1-05(Journal)
==========================================================

Created: 2024-05-25 08:31:29
ConfID: 7323269
CauseID: 1630467729
OtherID: 1630219793
JT: FOCUS Endocrinology
MD: Ushanova,5,1,42,2024,Review of international clinical guidelines for the management of hypertension in patients with diabetes mellitus?
DOI: 10.15829/2713-0177-2024-5-1-06(Journal) (7323269-N)
DOI: 10.62751/2713-0177-2024-5-1-06(Journal)
==========================================================

Created: 2024-05-25 08:31:29
ConfID: 7323268
CauseID: 1630467729
OtherID: 1630219793
JT: FOCUS Endocrinology
MD: Demidova,5,1,6,2024,Predictive models of high risk of heart failure, atherosclerotic diseases and CKD in patients with type 2 diabetes mellitus
DOI: 10.15829/2713-0177-2024-5-1-01(Journal) (7323268-N)
DOI: 10.62751/2713-0177-2024-5-1-01(Journal)
==========================================================

Created: 2024-05-25 08:31:29
ConfID: 7323267
CauseID: 1630467729
OtherID: 1630219793
JT: FOCUS Endocrinology
MD: Teplova,5,1,59,2024,Biochemical bases of the organoprotective properties of metformin
DOI: 10.15829/2713-0177-2024-5-1-08(Journal) (7323267-N)
DOI: 10.62751/2713-0177-2024-5-1-08(Journal)
==========================================================

Created: 2024-05-25 08:31:29
ConfID: 7323266
CauseID: 1630467729
OtherID: 1630219793
JT: FOCUS Endocrinology
MD: Demidova,5,1,24,2024,The effect of semaglutide on body weight in patients with type 2 diabetes mellitus
DOI: 10.15829/2713-0177-2024-5-1-04(Journal) (7323266-N)
DOI: 10.62751/2713-0177-2024-5-1-04(Journal)
==========================================================

Created: 2024-05-25 08:31:29
ConfID: 7323265
CauseID: 1630467729
OtherID: 1630219793
JT: FOCUS Endocrinology
MD: Belikina,5,1,20,2024,The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus
DOI: 10.15829/2713-0177-2024-5-1-03(Journal) (7323265-N)
DOI: 10.62751/2713-0177-2024-5-1-03(Journal)
==========================================================

Created: 2024-05-25 08:31:29
ConfID: 7323264
CauseID: 1630467729
OtherID: 1630219793
JT: FOCUS Endocrinology
MD: Khamidullina,5,1,14,2024,Course of coronavirus infection in patients with type 2 diabetes mellitus
DOI: 10.15829/2713-0177-2024-5-1-02(Journal) (7323264-N)
DOI: 10.62751/2713-0177-2024-5-1-02(Journal)